AccuStem Sciences, Inc.
ACUT
$0.55
$0.1330.95%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -28.48% | -54.11% | -48.47% | -54.74% | -45.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.60% | -50.45% | -46.52% | -53.98% | -45.26% |
| Operating Income | 26.60% | 50.45% | 46.52% | 53.98% | 45.26% |
| Income Before Tax | 26.60% | 50.45% | 46.52% | 53.98% | 45.26% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 26.60% | 50.45% | 46.52% | 53.98% | 45.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 26.60% | 50.45% | 46.52% | 53.98% | 45.26% |
| EBIT | 26.60% | 50.45% | 46.52% | 53.98% | 45.26% |
| EBITDA | 26.65% | 50.51% | 46.57% | 54.03% | 45.32% |
| EPS Basic | 27.17% | 50.45% | 46.54% | 53.98% | 46.76% |
| Normalized Basic EPS | 27.17% | 50.42% | 46.50% | 53.98% | 46.75% |
| EPS Diluted | 27.17% | 50.45% | 46.54% | 53.98% | 46.76% |
| Normalized Diluted EPS | 27.17% | 50.42% | 46.50% | 53.98% | 46.75% |
| Average Basic Shares Outstanding | 0.78% | -0.01% | 0.01% | 0.03% | 3.02% |
| Average Diluted Shares Outstanding | 0.78% | -0.01% | 0.01% | 0.03% | 3.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |